Furthermore, it was found that patients treated with first line platinum/paclitaxel for ovarian cancer had a poor overall and disease-free survival if the tumor exhibited methylated ASS1 compared to unmethylated ASS1 [22, 28]. This evidence concerns the gene ASS1 and neoplasm.